147 related articles for article (PubMed ID: 26535633)
1. Clinical significance of CD44 expression in children with hepatoblastoma.
Cai HY; Yu B; Feng ZC; Qi X; Wei XJ
Genet Mol Res; 2015 Oct; 14(4):13203-7. PubMed ID: 26535633
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour?
Turato C; Buendia MA; Fabre M; Redon MJ; Branchereau S; Quarta S; Ruvoletto M; Perilongo G; Grotzer MA; Gatta A; Pontisso P
Eur J Cancer; 2012 May; 48(8):1219-26. PubMed ID: 21737255
[TBL] [Abstract][Full Text] [Related]
4. [Expression of GRP78 and GRP94 in the liver tissues and their clinicopathological significance in children with hepatoblastoma].
Chen GN; Ma Y; Yang ZL
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Aug; 12(8):634-6. PubMed ID: 20704797
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma.
Shim YH; Park HJ; Choi MS; Kim JS; Kim H; Kim JJ; Jang JJ; Yu E
Mod Pathol; 2003 May; 16(5):430-6. PubMed ID: 12748249
[TBL] [Abstract][Full Text] [Related]
6. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma.
Hiyama E; Yamaoka H; Matsunaga T; Hayashi Y; Ando H; Suita S; Horie H; Kaneko M; Sasaki F; Hashizume K; Nakagawara A; Ohnuma N; Yokoyama T
Br J Cancer; 2004 Aug; 91(5):972-9. PubMed ID: 15280920
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma.
Yun WJ; Shin E; Lee K; Jung HY; Kim SH; Park YN; Yu E; Jang JJ
Pathol Res Pract; 2013 Sep; 209(9):568-73. PubMed ID: 23920322
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of dishevelled-2 inhibits cell proliferation and invasion in hepatoblastoma.
Huang S; Chen J; Tian R; Wang J; Xie C; Gao H; Shan Y; Hong J; Zhang Z; Xu M; Gu S
Pediatr Blood Cancer; 2018 Jul; 65(7):e27032. PubMed ID: 29528187
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of aminopeptidase-N (CD13) in hepatoblastoma.
Saida S; Watanabe K; Kato I; Fujino H; Umeda K; Okamoto S; Uemoto S; Hishiki T; Yoshida H; Tanaka S; Adachi S; Niwa A; Nakahata T; Heike T
Pediatr Int; 2015 Aug; 57(4):558-66. PubMed ID: 25682862
[TBL] [Abstract][Full Text] [Related]
10. Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression predicts metachronous pulmonary metastasis and poor survival in patients with hepatoblastoma.
Tsukada M; Wakai T; Matsuda Y; Korita PV; Shirai Y; Ajioka Y; Hatakeyama K; Kubota M
J Pediatr Surg; 2009 Aug; 44(8):1522-8. PubMed ID: 19635299
[TBL] [Abstract][Full Text] [Related]
11. [Glypican 3 expression in hepatoblastoma and its diagnostic implication].
Wang FH; Wen JM; Vong HT; Yip YC
Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):806-9. PubMed ID: 24507097
[TBL] [Abstract][Full Text] [Related]
12. SALL4 is a marker of the embryonal subtype of hepatoblastoma.
Gnemmi V; Leteurtre E; Sudour-Bonnange H; Devisme L; Guettier C; Buob D; Leroy X
Histopathology; 2013 Sep; 63(3):425-8. PubMed ID: 23822878
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical assessment of the MIB-1 Labeling Index in human hepatoblastoma and its prognostic relevance.
Ara T; Fukuzawa M; Oue T; Komoto Y; Kusafuka T; Imura K; Okada A
J Pediatr Surg; 1997 Dec; 32(12):1690-4. PubMed ID: 9434000
[TBL] [Abstract][Full Text] [Related]
14. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
[TBL] [Abstract][Full Text] [Related]
16. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?
Aretz S; Koch A; Uhlhaas S; Friedl W; Propping P; von Schweinitz D; Pietsch T
Pediatr Blood Cancer; 2006 Nov; 47(6):811-8. PubMed ID: 16317745
[TBL] [Abstract][Full Text] [Related]
17. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
18. Expression of glypican-3 is highly associated with pediatric hepatoblastoma: a systemic analysis.
Xiong XL; Qin H; Yan SQ; Zhou LS; Chen P; Zhao D
Asian Pac J Cancer Prev; 2015; 16(3):1029-31. PubMed ID: 25735325
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological and immunohistochemical study of hepatoblastoma].
Zhang X; Li F; Cheng N
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Sep; 29(3):298-301. PubMed ID: 10684098
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor-4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro.
Hsiao CC; Kao YH; Huang SC; Chuang JH
Pediatr Blood Cancer; 2013 Feb; 60(2):248-53. PubMed ID: 22648929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
